1887

Abstract

The aim of this study was to characterize the cerebrospinal fluid (CSF) prion protein (PrP) of healthy and naturally scrapie-affected sheep. The soluble form of CSF PrP immunoblotted with an anti-octarepeat and an anti-C terminus mAb showed two isoforms of approximately 33 and 26 kDa, corresponding to the biglycosylated and unglycosylated isoforms of brain PrP. Neither the mean concentration nor the electrophoretic profile of CSF PrP differed between healthy and scrapie-affected sheep, whereas a slightly increased resistance of CSF PrP to mild proteolysis by proteinase K was evident in the CSF of scrapie-affected sheep. No difference in susceptibility to proteolysis was observed between the two ARR and VRQ genetic variants of the purified prokaryote recombinant PrP. It was concluded that the physicochemical properties of PrP in the CSF could be altered during scrapie and that these changes might reflect the physiopathological process of prion disease.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81859-0
2006-12-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/12/3723.html?itemId=/content/journal/jgv/10.1099/vir.0.81859-0&mimeType=html&fmt=ahah

References

  1. Andréoletti O., Berthon P., Marc D., Sarradin P., Grosclaude J., van Keulen L., Schelcher F., Elsen J.-M., Lantier F. 2000; Early accumulation of PrPSc in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol 81:3115–3126
    [Google Scholar]
  2. Banks W. A., Niehoff M. L., Adessi C., Sote C. 2004; Passage of murine scrapie prion protein across the mouse vascular blood–brain barrier. Biochem Biophys Res Commun 318:125–130 [CrossRef]
    [Google Scholar]
  3. Baron T. G. M., Madec J.-Y., Calavas D. 1999; Similar signature of the prion protein in natural sheep scrapie and bovine spongiform encephalopathy-linked diseases. J Clin Microbiol 37:3701–3704
    [Google Scholar]
  4. Baylis M., Chihota C., Stevenson E., Goldmann W., Smith A., Sivam K., Tongue S., Gravenor M. B. 2004; Risk of scrapie in British sheep of different prion protein genotype. J Gen Virol 85:2735–2740 [CrossRef]
    [Google Scholar]
  5. Bieschke J., Giese A., Schulz-Schaeffer W., Zerr I., Poser S., Eigen M., Kretzschmar H. 2000; Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci U S A 97:5468–5473 [CrossRef]
    [Google Scholar]
  6. Brown P., Gibbs C. J., Rodgers-Johnson P., Asher D. M., Sulima M. P., Bacote A., Goldfarb L. G., Gajdusek D. C. 1994; Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529 [CrossRef]
    [Google Scholar]
  7. Buschmann A., Kuczius T., Bodemer W., Groschup M. H. 1998; Cellular prion proteins of mammalian species display an intrinsic partial proteinase K resistance. Biochem Biophys Res Commun 253:693–702 [CrossRef]
    [Google Scholar]
  8. Ecroyd H., Sarradin P., Dacheux J.-L., Gatti J.-L. 2004; Compartmentalization of prion isoforms within the reproductive tract of the ram. Biol Reprod 71:993–1001 [CrossRef]
    [Google Scholar]
  9. Elsen J.-M., Amigues Y., Schelcher F. & 7 other authors 1999; Genetic susceptibility and transmission factors in scrapie: detailed analysis of an epidemic in a closed flock of Romanov. Arch Virol 144:431–445 [CrossRef]
    [Google Scholar]
  10. Green A. J. E. 2002; Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt–Jakob disease. Neuropathol Appl Neurobiol 28:427–440 [CrossRef]
    [Google Scholar]
  11. Hunter N., Goldmann W., Foster J. D., Cairns D., Smith G. 1997; Natural scrapie and PrP genotype: case-control studies in British sheep. Vet Rec 141:137–140 [CrossRef]
    [Google Scholar]
  12. Le Dur A., Béringue V., Andréoletti O. & 8 other authors 2005; A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A 102:16031–16036 [CrossRef]
    [Google Scholar]
  13. Morel N., Simon S., Frobert Y., Volland H., Mourton-Gilles C., Negro A., Sorgato M. C., Créminon C., Grassi J. 2004; Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrils. J Biol Chem 279:30143–30149 [CrossRef]
    [Google Scholar]
  14. Moudjou M., Frobert Y., Grassi J., La Bonnardière C. 2001; Cellular prion protein status in sheep: tissue-specific biochemical signatures. J Gen Virol 82:2017–2024
    [Google Scholar]
  15. Rezaei H., Marc D., Choiset Y., Takahashi M., Hui Bon Hoa G., Haertlé T., Grosclaude J., Debey P. 2000; High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility. Eur J Biochem 267:2833–2839 [CrossRef]
    [Google Scholar]
  16. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F. E., Prusiner S. B. 1998; Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4:1157–1165 [CrossRef]
    [Google Scholar]
  17. Toutain P.-L. 2002; Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine. AAPS PharmSci 4:E38 [CrossRef]
    [Google Scholar]
  18. Weller R. O. 1998; Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol 57:885–894 [CrossRef]
    [Google Scholar]
  19. Wong B.-S., Green A. J. E., Li R., Xie Z., Pan T., Liu T., Chen S. G., Gambetti P., Sy M.-S. 2001; Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt–Jakob disease. J Pathol 194:9–14 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81859-0
Loading
/content/journal/jgv/10.1099/vir.0.81859-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error